quinolinic acid has been researched along with Parkinson Disease, Secondary in 6 studies
Quinolinic Acid: A metabolite of tryptophan with a possible role in neurodegenerative disorders. Elevated CSF levels of quinolinic acid are correlated with the severity of neuropsychological deficits in patients who have AIDS.
pyridinedicarboxylic acid : Any member of the class of pyridines carrying two carboxy groups.
quinolinic acid : A pyridinedicarboxylic acid that is pyridine substituted by carboxy groups at positions 2 and 3. It is a metabolite of tryptophan.
Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Thomsen, MB | 1 |
| Jacobsen, J | 1 |
| Lillethorup, TP | 1 |
| Schacht, AC | 1 |
| Simonsen, M | 1 |
| Romero-Ramos, M | 1 |
| Brooks, DJ | 1 |
| Landau, AM | 1 |
| Schapira, AH | 1 |
| Miranda, AF | 1 |
| Sutton, MA | 1 |
| Beninger, RJ | 1 |
| Jhamandas, K | 1 |
| Boegman, RJ | 1 |
| Guzman, R | 1 |
| Lövblad, KO | 1 |
| Meyer, M | 1 |
| Spenger, C | 1 |
| Schroth, G | 1 |
| Widmer, HR | 1 |
| Oo, TF | 1 |
| Siman, R | 1 |
| Burke, RE | 1 |
| Burton, S | 1 |
| Daya, S | 1 |
| Potgieter, B | 1 |
1 review available for quinolinic acid and Parkinson Disease, Secondary
| Article | Year |
|---|---|
The use of toxins to elucidate neural function and disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Brain; Brain Diseases; Disease Models, Animal; Humans; | 1993 |
5 other studies available for quinolinic acid and Parkinson Disease, Secondary
| Article | Year |
|---|---|
In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C]UCB-J PET.
Topics: Animals; Anticonvulsants; Autoradiography; Corpus Striatum; Female; Huntington Disease; Hydroxydopam | 2021 |
Quinolinic acid lesion of the nigrostriatal pathway: effect on turning behaviour and protection by elevation of endogenous kynurenic acid in Rattus norvegicus.
Topics: Alanine; Animals; Corpus Striatum; Excitatory Amino Acid Antagonists; Hydrolases; Kynurenic Acid; Ky | 1999 |
Imaging the rat brain on a 1.5 T clinical MR-scanner.
Topics: Animals; Artifacts; Blood-Brain Barrier; Brain; Brain Tissue Transplantation; Female; Huntington Dis | 2000 |
Distinct nuclear and cytoplasmic localization of caspase cleavage products in two models of induced apoptotic death in dopamine neurons of the substantia nigra.
Topics: Actins; Animals; Antibody Specificity; Apoptosis; Caspases; Cell Compartmentation; Cell Nucleus; Cyt | 2002 |
Melatonin modulates apomorphine-induced rotational behaviour.
Topics: Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Hun | 1991 |